Navigation Links
Nile Therapeutics, Inc. to Present at Upcoming BIO CEO & Investor Conference
Date:2/5/2008

BERKELEY, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Nile Therapeutics, Inc. (OTC Bulletin Board: NILT), announced today that Peter M. Strumph, Chief Executive Officer, will present at the BIO CEO & Investor Conference at the Waldorf-Astoria Hotel in New York City on Tuesday, February 12, 2008 at 11:00 a.m. EST. Mr. Strumph will provide an overview of Nile and an update on its clinical development programs.

The presentation will be webcast live and can be accessed by visiting the Investor Relations section at http://www.nilethera.com. The webcast will be archived for ninety days. Additional information regarding the BIO Investor Forum can be accessed at http://ceo.bio.org.

About Nile Therapeutics

Nile Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops innovative products for the treatment of cardiovascular disease and other areas of unmet medical need. Nile is initially focusing its efforts on developing its lead compound, CD-NP, a novel chimeric peptide in Phase I studies for the treatment of acute decompensated heart failure, and 2NTX-99, a small molecule, pre-clinical, anti-atherothrombotic agent with nitric oxide donating properties. A key component of the Company's strategy is to acquire the global rights to additional compounds to expand its portfolio. More information on Nile can be found at http://www.nilethera.com.

Contact:

Daron Evans

Chief Financial Officer

Nile Therapeutics, Inc.

510-281-7700

info@nilethera.com

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve substantial risks and uncertainties. All statements, other than statements of histor
'/>"/>

SOURCE Nile Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Velcura Therapeutics, Inc. Teams with International Discovery Sourcing Consultants to Develop New Therapeutic Molecules for Cancer and Bone Disease
2. Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimers Treatments
3. Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc.
4. Cell Therapeutics, Inc. (CTI) Shareholders Authorize Share Increase at Special Meeting of Shareholders
5. Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA
6. Cell Therapeutics, Inc. (CTI) Prices $1.27 million (euros 856.000) Offering of Common Stock through Societe Generale
7. Cell Therapeutics, Inc. Announces Authorization to Publish Italian Listing Prospectus
8. Cell Therapeutics, Inc. (CTI) Hosts Conference Call to Discuss Update on Zevalin(R) Acquisition, CMS Reimbursement, and PIX301 Timeline
9. Pearl Therapeutics, Inc. Expands Its Senior Management Team With Top Talent in Clinical Development and Regulatory Affairs
10. Cell Therapeutics, Inc. (CTI) to Submit Marketing Authorization Application for XYOTAX(TM) for First-line Non-small Cell Lung Cancer Ahead of Schedule
11. Cell Therapeutics, Inc. Announces Issuance of $23.25 Million in New Convertible Senior Notes in Exchange for $36.08 Million of Existing Convertible Senior Subordinated and Subordinated Notes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...ational Advisory Committee on Climate Change (NACC... Project in collaboration with the Vanuatu Meteoro...nd have generated preliminary climate change and s...d for the country’s SNC reporting to the Uni... (UNFCCC). , Port Vila, ...
(Date:11/25/2009)... Research Triangle Park-based Cnan...e-treatment water purification system NanoPure(TM)..., Minister of Rural Water Supply, Hon. Minister Vi.... Initial tests, performed at Indian Institute of ...ty of the drinking water available in India contai...
(Date:11/25/2009)... /PRNewswire-Asia/ -- Sinovac Biotech Ltd. ( SVA),...ounced today that it executed,a joint venture (JV)...echnology Co., Ltd. (Sinovac Dalian). The JV will ...-use vaccines. Sinovac will contribute its experti...g world-class vaccines; the,other party will bring...
(Date:11/24/2009)... also Visit Detroit , (Vo...rench Ambassador for International Investment, and..., , , ,What: Ambassador Appia is available to mee...tives adopted by France to further develop the fin...on and development., , ,When: Available for Interv...
Breaking Biology Technology:Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3
...poration,s ("Phlo"") (OTC: PHLC) press release of ...to Metropolitan New York City Account,Base," an af...at the,Company,s distributor in Metropolitan New Y...ollowing initial retail accounts of its key accoun...ently available for sale to the,public in the reta...
...ies, Inc. (Nasdaq: EMIS ), a biopharmaceutical co...ry of therapeutic molecules using its,eligen(R) te...s,presentation at the BIO CEO & Investor Conferenc...should go to the Investor Relations page of the,Em...sp at 2:45 PM to hear,the live presentation. Mich...
...ag(R),the world-leading equipment for non-invasive...alography (MEG) technology, has been ordered by Th...://www.newscom.com/cgi-bin/prnh/20020318/ELEKTALOG...n and extraordinary patient,care, The Nebraska Med...ospital of Distinction award for three consecutive...
Other Biology Technology:Phlo Affiliate Reports Progress in New York City Metropolitan Area Roll-Out 2Emisphere Technologies to Web Cast BIO CEO & Investor Conference Presentation February 12 2Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to The Nebraska Medical Center 2Elekta Chosen to Deliver Sophisticated Brain Mapping Technology to The Nebraska Medical Center 3
(Date:11/25/2009)...olice officers and ambulance workers faced a terri...lex. They battled to save people from the collapsi...res and evacuated as many people as they could in .... And making their jobs even harder was the proble...heir relatives jammed mobile networks with calls a...
(Date:11/25/2009)...ant professors recently received funding from the ...arch beneficial to understanding the environment. ...lackwood, assistant professor in the Department of...t two separate research projects. , His first pr...ities and Functions from the Leaf to the Landscape...
(Date:11/24/2009)...ors to understanding how sounds associated with Na...al or if they hear it at all. , The same type o...uses to detect flaws in the space shuttle,s behemo...o peek inside the giant head of a whale. The scans... of a whale,s hearing anatomy using a breakthrough...
Breaking Biology News(10 mins):Magic box for mission impossible 2Magic box for mission impossible 3Kent State University professors focus research on the environment with grants totaling $890,000 2Rocket science leads to new whale discovery 2Risk of abnormally slow heart rate twice as high in those taking drugs to slow Alzheimers 58690 1Risk of abnormally slow heart rate twice as high in those taking drugs to slow Alzheimers 58690 2Self monitoring of blood glucose levels helps patients with diabetes 58686 1Study shows that color plays musical chairs in the brain 10223 1Study shows that color plays musical chairs in the brain 10223 2Study shows that color plays musical chairs in the brain 10223 3
...eview by researchers at the Montreal Neurological ...ity of Cambridge, England provides vital insights ...igating Parkinson,s disease patients, who in some ...ng medical treatment. The review, published in thi...rnal Neuron , illustrates that persistently eleva...
...stical model could be used to predict an individua...e Children,s Hospital Informatics Program (CHIP). ...ts, the researchers showed that their predictive m...f cardioembolic stroke -- the most common form of ...re reported in the March issue of Stroke . , "Fo...
... scientists and social scientists led by the ESRC ...gh, calls for joined-up thinking on the emerging p...orld is waking up to the potential of plants from...ks, there is growing talk of plants replacing oil ...such fame comes at a price. , Recent ,food versu...
Other Biology News:Addiction: Insights from Parkinson's disease 2Predicting risk of stroke from one's genetic blueprint 2Plants are political hot potatoes 2
Mouse Anti-JNK, phospho (Thr183 / Thr185) Antibody, Unconjugated from Raybiotech, Inc.
Mouse Anti-Kaede Monoclonal Antibody, Unconjugated, Clone 2F4 from MBL International
Anti-AANAT Antibody, Unconjugated from CHEMICON
Mouse Anti-TUP1 Monoclonal Antibody, Unconjugated, Clone 10 from Exalpha Biologicals, Inc.
Biology Products: